Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.
Di Matteo A, De Lorenzis E, Duquenne L, Nam JL, Garcia-Montoya L, Harnden K, Chowdhury R, Wakefield RJ, Emery P, Mankia K. Di Matteo A, et al. Among authors: harnden k. Rheumatology (Oxford). 2024 Aug 1;63(8):2213-2221. doi: 10.1093/rheumatology/kead570. Rheumatology (Oxford). 2024. PMID: 37934127 Free PMC article.
Rheumatoid arthritis.
Harnden K, Pease C, Jackson A. Harnden K, et al. BMJ. 2016 Mar 23;352:i387. doi: 10.1136/bmj.i387. BMJ. 2016. PMID: 27009280 Free article. No abstract available.
Cardio-Oncology Program Building: A Practical Guide.
Bloom MW, Ferrari AM, Stojanovska J, Harnden KK, Beckford Y, Skurka K, Barac A. Bloom MW, et al. Among authors: harnden kk. Cardiol Clin. 2025 Feb;43(1):195-207. doi: 10.1016/j.ccl.2024.09.005. Epub 2024 Oct 18. Cardiol Clin. 2025. PMID: 39551558 Review.
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study.
Jhaveri KL, Lim E, Jeselsohn R, Ma CX, Hamilton EP, Osborne C, Bhave M, Kaufman PA, Beck JT, Manso Sanchez L, Parajuli R, Wang HC, Tao JJ, Im SA, Harnden K, Yonemori K, Dhakal A, Neven P, Aftimos P, Pierga JY, Lu YS, Larson T, Jerez Y, Sideras K, Sohn J, Kim SB, Saura C, Bardia A, Sammons SL, Bacchion F, Li Y, Yuen E, Estrem ST, Rodrik-Outmezguine V, Nguyen B, Ismail-Khan R, Smyth L, Beeram M. Jhaveri KL, et al. Among authors: harnden k. J Clin Oncol. 2024 Sep 6:JCO2302733. doi: 10.1200/JCO.23.02733. Online ahead of print. J Clin Oncol. 2024. PMID: 39241211
35 results